25% Umuti wa Tilmicosine Umunwa winkoko
.png)
.png)
.png)
.png)
Ibigize
100ml irimo 25g Tilmicosine.
Igikorwa cya farumasi
Pharmacodynamics Teicoplanin ni antibiyotike ya semrolitike ya macrolide yeguriwe inyamaswa.Kuri mycoplasma, ingaruka za antibacterial zirasa na tylosine, kandi bagiteri zifite garama nziza ni Staphylococcus aureus (harimo na penisiline irwanya Staphylococcus aureus), pneumococcus, streptococcus, Bacillus anthracis, Erysipelothref rhusiopathus emphysematosus.Indwara ya bacteri yunvikana irimo Haemophilus, meningococcus na Pasteurella.Irakora cyane kuruta tylosine irwanya Actinobacillus pleuropneumoniae, Pasteurella na Mycoplasma bovis.Mirongo cyenda na gatanu kwijana rya Pasteurella haemolytica irashobora kwibasirwa niki gicuruzwa.
Imiti ya farumasi
Umuti wa Tilmicosine winjizwa vuba nyuma yubuyobozi bwo mu kanwa kandi ukarangwa no kwinjiza ingirabuzimafatizo zikomeye hamwe no gukwirakwiza kwinshi (kurenza 2 L / kg).Ubwinshi bwibihaha nibwinshi, kurandura igice cyubuzima bushobora kugera kumunsi 1 kugeza kuri 2, kandi plasma yibitseho neza ikomeza igihe kirekire.
Imikoreshereze yibiyobyabwenge
(1) Tilmicosine ifite intego imwe nizindi macrolide na lincosamine kandi ntigomba gukoreshwa icyarimwe.
(2) guhuza hamwe na β-lactams yerekanaga antagonism.
Igihe cyo gukuramo
Iminsi 27 mbere yo kubagwa.
Ntabwo ari ugukoresha inka zamata yimyaka yo kororoka, cyangwa mumatungo ayo ari yo yose muminsi 45 yambere yo gutwita (cyangwa iminsi 45 yambere nyuma yo gukuraho ikimasa)
Igikorwa no gukoresha
Antibiyotike ya Macrolide.Ikoreshwa mukuvura indwara zubuhumekero zinkoko ziterwa na Pasteurella na Mycoplasma.
Imikoreshereze nubuyobozi
Ibinyobwa bivanze: 0,3 ml kuri 1 L y'amazi y'inkoko.Iminsi 3.
Ingaruka mbi
Ingaruka z'ubumara bw'iki gicuruzwa ku nyamaswa ahanini ni sisitemu y'umutima n'imitsi, ishobora gutera tachycardia no kugabanuka kw'imitsi
Kwirinda
Umuti wa Tilmicosine mu kanwa urabujijwe gutera inkoko mugihe cyo gutera.
Igihe cyo gukuramo
Inkoko iminsi 12.
Ububiko
Ubike muburyo bufunze, burinzwe kumucyo.
Hebei Veyong pharmaceutical Co., Ltd yashinzwe mu 2002, iherereye mu mujyi wa Shijiazhuang, Intara ya Hebei, mu Bushinwa, iruhande rw’umurwa mukuru wa Beijing.Ni ikigo kinini cyemewe na GMP cyemewe n’ibiyobyabwenge, hamwe na R&D, gukora no kugurisha amatungo ya APIs, imyiteguro, ibiryo byateganijwe hamwe ninyongeramusaruro.Nka Centre Tekinike yintara, Veyong yashyizeho uburyo bushya bwa R&D kumiti yubuvuzi bwamatungo, kandi nicyo kigo kizwi cyane mu guhanga udushya mu ikoranabuhanga rishingiye ku buvuzi bw’amatungo, hari abahanga mu bya tekinike 65.Veyong ifite ibishingwe bibiri: Shijiazhuang na Ordos, muri byo ikigo cya Shijiazhuang gifite ubuso bwa m2 78,706 m2, hamwe n’ibicuruzwa 13 bya API birimo Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, n'imirongo 11 yo gutegura harimo gutera inshinge, igisubizo cyo mu kanwa, ifu , premix, bolus, imiti yica udukoko hamwe na disinfectant, ects.Veyong itanga APIs, zirenga 100 bwite- label itegura, na serivisi ya OEM & ODM.
Veyong yita cyane ku micungire ya sisitemu ya EHS (Ibidukikije, Ubuzima & Umutekano), kandi yabonye impamyabumenyi ya ISO14001 na OHSAS18001.Veyong yashyizwe ku rutonde rw’inganda zigenda ziyongera mu Ntara ya Hebei kandi irashobora gutanga ibicuruzwa bikomeza.
Veyong yashyizeho uburyo bwuzuye bwo gucunga neza, yabonye icyemezo cya ISO9001, icyemezo cya GMP mu Bushinwa, icyemezo cya Ositarariya APVMA GMP, icyemezo cya Etiyopiya GMP, icyemezo cya Ivermectin CEP, kandi yatsinze igenzura rya FDA muri Amerika.Veyong ifite itsinda ryumwuga ryo kwiyandikisha, kugurisha na serivisi ya tekiniki, isosiyete yacu imaze kwiringira no gushyigikirwa nabakiriya benshi kubwiza bwibicuruzwa byiza, ubuziranenge bwiza mbere yo kugurisha na nyuma yo kugurisha, gucunga neza na siyansi.Veyong yakoze ubufatanye burambye n’inganda nyinshi zizwi cyane mu bya farumasi y’imiti n’ibicuruzwa byoherezwa mu Burayi, Amerika y'Epfo, Uburasirazuba bwo hagati, Afurika, Aziya, n'ibindi bihugu birenga 60.
